Rethinking hereditary angioedema: What role can the first oral plasma kallikrein inhibitor play?
Rethinking hereditary angioedema: What role can the first oral plasma kallikrein inhibitor play?
Reflection on hereditary angioedema (HAE): Progress and perspectives
Marcin Stobiecki
A new view: What is the role of berotralstat?
Emel Aygören-Pürsün
Changing times: How can we optimise patient transition between therapies?
Marcin Stobiecki
From clinical data to real-world evidence: Does the reality match the theory?
Delphine Gobert
Applied thinking: What can we learn from the evidence?
Sorena Kiani-Alikhan
Looking ahead in HAE: What should our vision be?
Marcin Stobiecki